Nexera sets $1.6148 exercise price on warrants
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Nexera Technologies Ltd (NEXR) reports that, effective as of September 3, 2026, the exercise price per whole Ordinary Share issuable upon exercise of its outstanding Series A Warrants issued on January 29, 2024 and the warrant issued on June 18, 2026 in connection with a convertible promissory note was adjusted to $1.6148, subject to further adjustments under their terms.
No other changes, adjustments or modifications were made to the Series A Warrants or the June 2026 Note Warrant. This report is incorporated by reference into Nexera Technologies Ltd’s existing Registration Statements on Form F-3 and Form S-8 listed in the filing.
Key Figures
Key Terms
Series A Warrants financial
convertible promissory note financial
Registration Statements on Form F-3 regulatory
Registration Statements on Form S-8 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What warrant change did Nexera Technologies Ltd (NEXR) disclose in this Form 6-K?
Which Nexera (NEXR) warrants are affected by the new $1.6148 exercise price?
Were any other terms of Nexera Technologies’ (NEXR) warrants changed?
From what date is the new $1.6148 exercise price effective for NEXR warrants?
How is this Nexera (NEXR) Form 6-K used in existing registration statements?
AI-generated analysis. How Rhea-AI works. Not financial advice.